Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients

Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients

<p>Abstract</p> <p>Background</p> <p>HIV-monoinfected patients may be at risk for significant liver fibrosis, but its prevalence and determinants in these patients are unknown. Since HIV-monoinfected patients do not routinely undergo liver biopsy, we evaluated the preva...

Full description

Bibliographic Details
Main Authors:	Localio Russell, Amorosa Valerianna K, DallaPiazza Michelle, Kostman Jay R, Lo Re Vincent
Format:	Article
Language:	English
Published:	BMC 2010-05-01
Series:	BMC Infectious Diseases
Online Access:	http://www.biomedcentral.com/1471-2334/10/116

Similar Items

Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy.
by: Tavitiya Sudjaritruk, et al.
Published: (2019-01-01)

PROGRESSION OF LIVER FIBROSIS IN MONOINFECTED PATIENTS BY HEPATITIS C VIRUS AND COINFECTED BY HCV AND HUMAN IMMUNODEFICIENCY VIRUS
by: Cristiane Valle TOVO, et al.
Published: (2013-03-01)

PROGRESSION OF LIVER FIBROSIS IN MONOINFECTED PATIENTS BY HEPATITIS C VIRUS AND COINFECTED BY HCV AND HUMAN IMMUNODEFICIENCY VIRUS
by: Cristiane Valle TOVO, et al.
Published: (2013-03-01)

Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients: Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors TIMPs and Effect of HCV Protease Inhibitors
by: Tiziana Latronico, et al.
Published: (2016-03-01)

Differences in the proviral HIV DNA between HIV monoinfected and HIV/HCV coinfected individuals
by: M.S. Carrillo, et al.
Published: (2017-12-01)

A Global Approach to Disease Prevention: Predicting High Risk Areas for West Nile Infection in the Us
by: DallaPiazza, Kristin Lee
Published: (2014)

Difference in Markers of Microbial Translocation and Cell Apoptosis in HIV Monoinfected and HIV/HCV Coinfected Patients
by: Madelāne Monta, et al.
Published: (2019-08-01)

Renal safety of tenofovir and/or entecavir in patients with chronic HBV monoinfection
by: Yang YM, et al.
Published: (2017-09-01)

Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
by: Nicolò de Gennaro, et al.
Published: (2020-03-01)

Comparative analysis of the safety of triple therapy with telaprevir between HCV monoinfected and HIV coinfected patients
by: C. Sangrador Pelluz, et al.
Published: (2014-01-01)

Cellular activation and intracellular HCV load in peripheral blood monocytes isolated from HCV monoinfected and HIV-HCV coinfected patients.
by: Isabelle Dichamp, et al.
Published: (2014-01-01)

Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China.
by: Yi Tan, et al.
Published: (2008-01-01)

Hepatocellular carcinoma in hepatitis D: Does it differ from hepatitis B monoinfection?
by: Zaigham Abbas, et al.
Published: (2012-01-01)

Tenofovir-induced Fanconi syndrome in a patient with chronic hepatitis B monoinfection
by: Fabio Conti, et al.
Published: (2016-03-01)

Proteomic Analysis of Serum and Urine of HIV-Monoinfected and HIV/HCV-Coinfected Patients Undergoing Long Term Treatment with Nevirapine
by: Jeerang Wongtrakul, et al.
Published: (2014-01-01)

The impact of the severity of HIV infection on the prevalence of liver fibrosis in children
by: Ida Bagus Gde Suwibawa Putra, et al.
Published: (2019-04-01)

The First Report of Immune Reconstitution Inflammatory Syndrome Complicated by Jarisch-Herxheimer Reaction
by: Michelle DallaPiazza MD, et al.
Published: (2017-07-01)

Treatment Outcomes with Telaprevir-Based Therapy for HIV/Hepatitis C Coinfected Patients are Comparable with Hepatitis C Monoinfected Patients
by: Conar R O’Neil, et al.
Published: (2015-01-01)

Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?
by: Autumn D Zuckerman, et al.
Published: (2019-01-01)

IMMUNOLOGICAL PARAMETERS IN PATIENTS WITH MONOINFECTION BY HUMAN PAPILLOMAVIRUS AND IN PATIENTS CO-INFECTED BY PAPILLOMAVIRUS AND UROGENITAL PATHOGENS
by: A. A. Savchenko, et al.
Published: (2014-08-01)

Comparing drug interaction frequencies of various hepatitis C treatment regimens among monoinfected patients
by: Alisha Ahmed, et al.
Published: (2019-07-01)

Effects on insulin sensitivity and hepatic safety of Atazanavir in HCV/HIV coinfected patients versus HIV monoinfected: A prostective 48-week study
by: Bello Laura, et al.
Published: (2010-05-01)

Prevalence and Determinants of Significant Liver Fibrosis by Vibration-Controlled Transient Elastography in Thai Chronic Hepatitis B Patients
by: Apichet Sirinawasatien, et al.
Published: (2018-01-01)

Fanconi syndrome and chronic renal failure in a chronic hepatitis B monoinfected patient treated with tenofovir
by: Pedro Magalhães-Costa, et al.

Monoinfections caused by Borrelia burgdorferi and Borrelia burgdorferi / Anaplasma phagocytophilum co-infections in forestry workers and farmers
by: Małgorzata Tokarska-Rodak, et al.
Published: (2015-10-01)

NONALCOHOLIC FATTY LIVER DISEASE: COMORBIDITIES, CLINICAL SIGNIFICANCE AND EVALUATION OF LIVER FIBROSIS
by: D. V. Marshalko, et al.
Published: (2018-02-01)

Clinical Relevance of Torque Teno Virus (TTV) in HIV/HCV Coinfected and HCV Monoinfected Patients Treated with Direct-Acting Antiviral Therapy
by: Daniele Lapa, et al.
Published: (2021-05-01)

Clinical features of nervous system disorders in patients with EBV as monoinfection and in association with other herpes viruses in their reactivation and persistence
by: A.O. Rudenko, et al.
Published: (2017-11-01)

Analysis of hepatitis C virus (HCV) RNA load in platelets of HCV-monoinfected patients receiving antiviral therapy
by: Márcia Paschoal do Espírito-Santo, et al.
Published: (2013-05-01)

A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection.
by: Nasheed Moqueet, et al.
Published: (2017-01-01)

Increased Prevalence of Liver Fibrosis and HIV Viremia among Patients with HIV, HBV, and Tuberculosis in Botswana
by: Bonolo B. Phinius, et al.
Published: (2020-11-01)

Platelet indices significantly correlate with liver fibrosis in HCV-infected patients.
by: Lin-Nan Shao, et al.
Published: (2020-01-01)

Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease
by: Chaoli Chen, et al.
Published: (2021-05-01)

Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease
by: José Tadeu Stefano, et al.
Published: (2021-01-01)

Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients
by: Kamil Grubczak, et al.
Published: (2021-07-01)

Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies
by: Maryam Ebadi, et al.
Published: (2021-08-01)

Prevalence in vulnerable population of liver fibrosis identified by transient elastography
by: Norberto Chávez-Tapia, et al.
Published: (2015-07-01)

Significance of connective tissue diseases features in pulmonary fibrosis
by: Vincent Cottin
Published: (2013-09-01)

Evaluating the Significance of Viscoelasticity in Diagnosing Early-Stage Liver Fibrosis with Transient Elastography.
by: Jingxin Zhao, et al.
Published: (2017-01-01)

Reply to: Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease
by: Claudia P. Oliveira
Published: (2021-05-01)

Cannot write session to /tmp/vufind_sessions/sess_lghj8chslueb3q07o0j17n5qpi